课题基金 / 基金详情

GALACTOSE METABOLIC PATHWAYS

GALACTOSE METABOLIC PATHWAYS
半乳糖代谢途径
批准号:
6415339
负责人:
LOUIS J ELSAS
金额:
$29.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2001-11-30

项目摘要

项目成果

LOUIS J ELSAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall hypothesis is that enigmatic clinical outcomes in patients with galactosemia who have identical molecular and biochemical mutations in red blood cell galactose-1-phosphate uridyltransferase (GALT) are caused by alternative pathways and organ-specific impairment for galactose metabolism. This hypothesis will be tested by quantitative and qualitative comparisons of in vivo galactose metabolic pathways in patients with galactosemia who are homozygous for the Q188R mutation, and have other defined mutations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPROVED OUTCOME PREDICTION IN GALACTOSEMIA NEWBORNS
GALACTOSE METABOLIC PATHWAYS
  • 批准号:
    6565726
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    LOUIS J ELSAS
  • 依托单位:
GALACTOSE METABOLIC PATHWAYS--BREATH TEST
  • 批准号:
    6565727
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    LOUIS J ELSAS
  • 依托单位:
PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU
  • 批准号:
    6586005
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    LOUIS J ELSAS
  • 依托单位:
海外基金